Wistar announces initiation of Phase 2 clinical study of VK-2019 in patients with advanced head and neck cancer
The Wistar Institute announces the initiation of a Phase 2 clinical study of VK-2019 in patients with advanced Epstein-Barr Virus (EBV)-positive nasopharyngeal carcinoma (NPC) and lymphoma.
A Dimitrios Colevas Paulm Lieberman Hilary Koprowski Troy Messick Emily Henderson Epstein Barr Nuclear
Source: news-medical.net